entertainment -WSS

entertainment

author：knowledge 2025-09-29 19:58:19 - browse：524

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The EU Joint Clinical Assessment needs to live up to its promise

WSS

Studies point to risks of excluding people with obesity from drug trials

Researchers explore possible ties between long Covid, menopause

Will Ozempic

5 takeaways from STAT's examination of Zynex Medical

Beam Therapeutics to lay off 20% of its staff, re

FDA gives detailed accounting of AI

entertainment

entertainment

entertainment

Virginia high school admissions case could be legal follow

The EU Joint Clinical Assessment needs to live up to its promise

Trump demands the U.S. pay no more for drugs than other countries … again

Lawmakers consider Medicare pay reforms for doctors

Supreme Court strikes down use of affirmative action

The system is set up to fail children with medical complexity

New air purifier tech could be key to improving indoor air quality

New report analyzes digital physical therapy solutions' effectiveness

Psychedelics group wrestles with new pharma identity

How climate

hotspot

Curing rare childhood diseases will falter unless Congress steps up

Eli Lilly expects to double planned employment in Boston center

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

The system is set up to fail children with medical complexity

How faith leaders like me can help address America's obesity epidemic

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

leisure time

focus

hotspot

entertainment